Baker Botts represented EDPR on the deal. EDPR NA Distributed Generation LLC (EDPR NA DG), the distributed generation (DG) business unit of EDP Renewables North America...
You must be a Standard 1 Year member to access this content.
Baker Botts represented Sunnova on the deal. Sunnova Energy International (Sunnova) (NYSE: NOVA), a leading Energy as a Service (EaaS) provider, announced a conditional commitment by...
You must be a Standard 1 Year member to access this content.
Crowell & Moring advised Rekor Systems, Inc. on the deal. Rekor Systems, Inc. (Nasdaq: REKR) entered into a definitive agreement for the issuance and sale in...
You must be a Standard 1 Year member to access this content.
Ballard Spahr represented OMERS Life Sciences on the deal. Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral...
You must be a Standard 1 Year member to access this content.
Ballard Spahr represented AJNA BioSciences PBC on the deal. AJNA BioSciences PBC announced the formation of a drug-development joint venture with Charlotte’s Web, Inc (TSX: CWEB), the...
You must be a Standard 1 Year member to access this content.
Bracewell LLP represented Competitive Power Ventures on the deal. Competitive Power Ventures announced the acquisition and financing of four operating wind farms in Maine from Patriot Renewables...
You must be a Standard 1 Year member to access this content.
Bracewell LLP represented PPL Electric Utilities Corporation on the deal. PPL Electric Utilities Corporation announced its recent public offering of $1,350,000,000 of its First Mortgage Bonds, 5.00%...
You must be a Standard 1 Year member to access this content.
Bracewell LLP represented Phillips 66 on the deal. Phillips 66 announced its public offering of $1.25 billion of senior notes issued. The Phillips 66 Company is...
You must be a Standard 1 Year member to access this content.
Cooley advised SJ Semiconductor Corporation (SJSemi) on the deal. Corporation (SJSemi), a semiconductor foundry, announced its $340 million Series C+ financing, with a post-money valuation of close...
You must be a Standard 1 Year member to access this content.
Cooley advised Theory Ventures on the deal. Theory Ventures, a venture capital investment firm, announced its $230 million debut fund. Founded by Tomasz Tunguz, Theory Ventures...
You must be a Standard 1 Year member to access this content.
Cooley advised Ensemble on the deal. Ensemble, an early-stage venture capital firm backed by category-defining advisers, announced its $100 million debut fund. ù Ensemble plans to use...
You must be a Standard 1 Year member to access this content.
Cooley advised SCYNEXIS on the deal. SCYNEXIS announced its exclusive license agreement with GSK for Brexafemme. The exclusive license agreement gives GSK rights to commercialize SCYNEXIS’ ibrexafungerp...
You must be a Standard 1 Year member to access this content.
